1. Liu, Yangyang, Li, Xiang, Cao, Chang, Zhang, Juyi, Li, Haiying. 2024. Critical role of Slc22a8 in maintaining blood-brain barrier integrity after experimental cerebral ischemia-reperfusion. In Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 45, 85-101. doi:10.1177/0271678X241264401. https://pubmed.ncbi.nlm.nih.gov/39068534/
2. Vávra, Jiří, Mančíková, Andrea, Pavelcová, Kateřina, Bohatá, Jana, Stibůrková, Blanka. 2022. Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort. In Cells, 11, . doi:10.3390/cells11071063. https://pubmed.ncbi.nlm.nih.gov/35406626/
3. Vanwert, Adam L, Srimaroeng, Chutima, Sweet, Douglas H. 2008. Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. In Molecular pharmacology, 74, 122-31. doi:10.1124/mol.107.042853. https://pubmed.ncbi.nlm.nih.gov/18381565/
4. Dahlin, Amber, Wittwer, Matthias, de la Cruz, Melanie, Gupta, Samir K, Giacomini, Kathleen M. . A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome. In Pharmacogenetics and genomics, 25, 82-92. doi:10.1097/FPC.0000000000000110. https://pubmed.ncbi.nlm.nih.gov/25485598/